Related Experiment Videos
[Chronic respiratory insufficiency in the child]
1Service de pneumologie pédiatrique Hôpital d'enfants Armand-Trousseau 75012 Paris. brigitte.fauroux@trs.ap-hop-paris.fr
Insights
Pediatric chronic respiratory insufficiency stems from diverse conditions. Advanced treatments like long-term oxygen therapy and non-invasive ventilation improve survival, but require further evaluation.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Critical Care
Context:
- Chronic respiratory insufficiency in children arises from various underlying diseases.
- Common causes include bronchopulmonary dysplasia in infants, and cystic fibrosis and neuromuscular disorders in older children.
- These conditions significantly impact a child's quality of life and long-term health outcomes.
Purpose:
- To review the primary causes of chronic respiratory insufficiency in pediatric populations.
- To highlight the advancements in supportive therapies, specifically long-term oxygen therapy (LTOT) and non-invasive mechanical ventilation (NIMV).
- To emphasize the need for objective evaluation of LTOT and NIMV to optimize their clinical application and patient benefits.
Summary:
- Chronic respiratory insufficiency in childhood is linked to a spectrum of diseases with varied prognoses.
- Bronchopulmonary dysplasia, cystic fibrosis, and neuromuscular diseases are leading causes in infants and older children, respectively.
- Improved survival and quality of life are observed with therapies like LTOT and NIMV.
Impact:
- Enhanced survival rates and improved quality of life for children with chronic respiratory insufficiency.
- Identification of key areas for further research and clinical trials concerning LTOT and NIMV.
- Potential for refined treatment guidelines and protocols to maximize therapeutic efficacy in pediatric respiratory care.
Abstract:
Chronic respiratory insufficiency in childhood can be caused by a heterogeneous group of diseases whose management and prognosis differ. Bronchopulmonary dysplasia in infants, and cystic fibrosis and neuromuscular diseases in older children, represent the most common causes of chronic respiratory insufficiency. The improvements in medical treatments, with the development of long term oxygen therapy and non invasive mechanical ventilation, have contributed to the increased survival and the better quality of life of these children. An objective evaluation of treatments, such as long term oxygen therapy and non invasive mechanical ventilation, are warranted to improve the indications and benefits of these therapies.